af Felicia MedStudent 16 år siden
1058
Mere som dette
MOA: DA and beta 1 receptor agonist
effects:
site 1
MOA: inhibits both isoforms of carbonic anhydrase, thus inhibiting HCO3 reabsorbtion which also decreases Na reabsorbtion
indications:
metabolic acidosis
b/c it lowers plasma HCO3
site 4
seldom used alone
contraindicated in pt with renal insufficiency
if pt. hypertensive or post-MI
epleronone
MOA: same as spironolactone, except...
specific for the mineralocorticoid receptor (does not bind androgen or progesterone receptors)
spironolactone
MOA: aldosterone receptor competitive antagonist
inhibs ability of aldosterone to increase the Na/K exchange
NOT specific for the mineralocorticoid receptor (also binds glucocorticoid receptors)
effects:
SLOW onset and offset
contraindications
pts w/ impaired renal function
pts w/ diabetes
anti-androgenic effects/hypoandrogenism
menstrual irregularities
impotence
gynecomastia
elevated aldosterone level (in those w/ HF)
hyperkalemia
ENaC
triamterene
oral
some hepatic metabolism
shorter t1/2
amiloride
MOA: removes the drive to transport K across the cell (for excretion) -- by inhibiting Na influx thru ENaC, so less Na for the NaK ATPase
oral
unmetabolized (excreted uncharged by the kidney!)
site 3
MOA: inhibits NCC (Na/Cl contransporter) -- inhibs NaCl reabsorbtion at DCT
unlike site 2 diuretics, DO NOT LEAD TO COUNTERCURRENT WASHOUT
contraindicated in pts with renal insufficiency!
indications
- essential HT
- CHF (w/ NORMAL renal fxn)
- mild edema
- hypocalcemia & hypercalciuria)
- diabetes insipidus (lack of ADNH)
increased urinary excretion of: Na, K, H
decreased urinary excretion of: Ca, urate, Lo
if pt has high cholesterol or diabetes...
metolazone & indapamide
don't cause hyperglycemia
don't alter lipids
exception to thiazide rule!: effective in renal failure when combined with a loop diuretic
better AE profile
drug interactions
hypokalemia increases digitalis toxicity!!!
glucocorticoids
Li
site 2 diuretics
K-sparing diuretics
may prevent K loss - a useful interaction
AE
hypersensitivity reactions
increased serum lipoproteins, TG, LDL
chlorthalidolone
cholorthizide & hydrocholrothiazide
ineffective when GFR < 30ml/min (low renal fxn)
site 2
longer t1/2 permits qd dosing
2x bioavailability as furosemide
ethacrynic acid and bumetanide have lower incidence of hyperglycemia
ethacrynic acid
no sulfonamide group!
bumetanide
potency differs from furosemide
furosemide
MOA: inhibits NKCC2 (by plugging up the Cl site) and also causes 'counter-current' washout
worsens gout
GI disturbances
hypertriglyceridemia
hyperglycemia
hyperaldosteronism
ototoxicity
hypokalemia
MOA: trap water in filtrate and osmotically prevent water reabsorbtion + cause diuresis by countercurrent washout
basically, they increase GFR by redistributing water from some place in the periphery to the kidney so that it can be eliminated
need some water in your body for an osmotic diuretic to redistribute it! osmotic diuretics would make dehydration worse
osmotic diuretics will increase the circulating [pre]load
Natriuretic diuretics are ok to use though b/c they don't increase preload - they alter renal dynamics at the nephron instead of throughout vasculature
increasing the vascular volume with an osmotic diuretic will make the peripheral edema worse -- backs up into lungs and can lead to pulmonary edema!
need at least SOME urine flow to get the osmotic diuretic out of your system
eventually the osmotic diuretics will diffuse from the plasma compartment out into the CSF -- the excess CSF volume can cause cerebral edema
as long as there is SOME urine production though
used mostly prior to ocular surgery